Applications in Medical Industry to Keep Cold Plasma Demand Afloat: Study
FMI’s recent report projects the cold plasma market to expand staggeringly, attributed to its increasing application in the healthcare industry to treat hospital acquired infections. In its new study that tracks markets across 20+ countries, the report opines demand from food processing industry to complement growth in addition to the sustained demand from healthcare sector.
Cold Plasma Market
A recent market study published by FMI on the Cold plasma market includes the global indus...
Additionally, recent clinical trials have established the effectiveness of cold plasma treatment in the removal of post-surgery cancer tumors, especially in the breast and lung segments. The treatment is widely accepted due to its ability to target malignant tissues and leave healthy ones intact.
Cold plasma treatment is also being touted as an effective remedy against the ongoing COVID-19 pandemic. The capability to neutralize over nine out of ten pathogens from the airstream is prompting healthcare providers to increase their research in this area of treatment.
- Low temperature atmospheric pressure plasma to capture the lion’s share during the forecast period
- Food processing & packaging slated to expand impressively due to increased awareness regarding food contamination due to surface pathogens
- Administration for healing chronic wounds to experience immense white spaces in terms of application
- North America to retain market hegemony, Asia-Pacific offer lucrative prospects in the textile industry
COVID-19 and the Cold Plasma Market
The novel coronavirus pandemic has substantially hindered growth prospects of the cold plasma market, especially in the chemicals, automotive manufacturing, food processing and textile industries. This is due to a major business crunch experienced by these industries due to mandatory lockdowns.
However, medical practitioners are advocating cold plasma as an effective remedy to treat positive patients, thus keeping its demand afloat in the healthcare industry. Based on trials conducted on adenoviruses and noroviruses, scientists are optimistic about the treatment successfully eradicating the novel coronavirus strain.
The overarching aim of healthcare practitioners is to administer the plasma intensive care on mechanically ventilated COVID-19 patients to reduce viral load and prevent bacterial pneumonia. This lucrative potential across the medical sector is anticipated to keep the market afloat in the short-run.
“Incumbent market players are highly emphasizing on diversifying their product portfolio by virtue of collaborations with leading academic & research institutes to augment their R&D operations, enabling them to introduce innovative products,” concludes the FMI analyst.
Prominent players within the global cold plasma market include Nordson Corporation, Europlasma NV, Plasmatreat GmBh, Terraplasma Medical GmBh, Henniker Plasma, US Medical Innovations, Molecular Plasma Group, Nordson Corporation, Adtech Plasma Technology Co Ltd., Smith & Nephew plc and Thierry Corporation to name a few.
In February 2020, Adtech Plasma Technology initiated a new project in collaboration with Hull York Medical School for testing gas plasma on osteomyelitis bone infections. The project will assist in establishing a laboratory testing model for evaluating and optimizing plasma treatment for osteomyelitis biofilm infections.
Plasmatreat has deployed a prototype cleaning station in conjunction with the Bavarian Red Cross for disinfecting single-use protective clothing for frontline COVID-19 healthcare workers.
In 2019, the Electronics & Photonic Innovation Center (EPIC) acquired a substantial number of UK-based Henniker Plasma’s HPT-200 plasma treatment system, thereby expanding their own business capabilities.
More Insights on the Cold Plasma Market
A recent market study published by FMI on the cold plasma market includes the global industry analysis of 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. The report involved detailed segmentation on the basis of regime, indication, end-use sector, application and region. Our analysts have conducted thorough research on the historical as well as current growth parameters of the market to obtain growth prospects with maximum precision.
About the Healthcare Division at Future Market Insights
Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business. Know more about our sector coverage here
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
- Global Digital Pathology Market
- Healthcare Regulatory Affairs Outsourcing Market
- Hdl Cholesterol Kits Market
- Single Dose Radiotherapy Services Market
- General Anesthesia Drugs Market
- Clinical Trials Market
- Injectable Drug Delivery Market
- Microfluidics Market
- Lab Automation Market
- Lung Cancer Surgery Market
- Veterinary Vaccines Market
- Prescription Delivery Services Market
- Vital Signs Monitoring Devices Market
- Weight Loss And Obesity Management Market
- Respiratory Pathogen Testing Market